Skip to content
Assyro AI
FDA Orange Book · active-ingredient family

Cupric sulfate

Cupric sulfate: 1 brand, 2 generics; first approved May 05, 1987; generic available.

Generic availableHas discontinued products
Generic status & protection

Generic available: 2 ANDA applications approved.

Brands (NDA)
1
Generics (ANDA)
2
Listed patents
0
Presentations
3

Brand (NDA) products

Originator applications
  • CUPRIC SULFATERLD
    NDA 0193501987
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.4MG COPPER/MLINJECTABLEINJECTIONDiscontinued

Generic (ANDA) products (2)

Abbreviated applications
  • CUPRIC SULFATE
    ANDA 2187452024
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.4MG COPPER/MLINJECTABLEINJECTIONDiscontinued
  • CUPRIC SULFATERS
    ANDA 2163242022
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.4MG COPPER/MLINJECTABLEINJECTIONRx

Listed patents

Orange Book patent file

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Approval history

FDA approval span
First approval
39 yr 11 mo ago
Most recent approval
2 yr 1 mo ago

Approvals span 1987–2024 across 3 FDA applications.

Brand (NDA) 133%
Generic (ANDA) 267%

Cupric sulfate: frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Related FDA reference tools

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.